MedTrace Logo

Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry

NCT06163807 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-03-30

No results posted yet for this study

Summary

Primary objective

\- To study the stability of different phenotypes and endotypes of asthma at 3, 5, and 7 years of follow-up and - in MEGA COHORT and in patients on biologic treatment

Secondary objective(s)

* To study biomarkers variation post-treatment in patients with and without Nasal Polyposis
* To demonstrate the existence of different subtypes of eosinophils that may be phenotypically and functionally heterogeneous
* To increase the number of patients in the cohort on biologic treatment to reach at least 900 (400 over the current cohort).

Conditions

  • Chronic Asthma

Interventions

DRUG

Antiasthmatic

real-life

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Principal Investigators

  • Joaquin Sastre · Fundacion Jimenez Diaz

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-06-02
Completion
2026-06-02

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06163807 on ClinicalTrials.gov